Navigation Links
FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Date:1/31/2008

growths. Interferon alfa-2b has similar actions to natural interferon. Pegylated interferon alfa-2b is a longer-acting form of interferon made by attaching an inert molecule called polyethylene glycol, or PEG, to the alpha interferon molecule. This modification increases the size of the interferon molecule and results in slower elimination from the body, allowing for less frequent dosing than required for standard interferon.

Peginterferon alfa-2b is not approved for treatment of melanoma. In the United States, peginterferon alfa-2b, marketed as PEGINTRON(TM), is indicated for use alone or with ribavirin for the treatment of chronic hepatitis C in patients with compensated liver disease who have not been previously treated with interferon alpha and who are at least 18 years of age.

In the EU, peginterferon alfa-2b and ribavirin combination therapy is approved for the treatment of chronic hepatitis C who have elevated transaminases without liver decompensation and who are positive for serum HCV-RNA or anti-HCV, including naive patients with clinically stable HIV co-infection and in patients who have failed previous treatment with interferon alpha (pegylated or nonpegylated) and ribavirin combination therapy or interferon alpha monotherapy. Peginterferon alfa-2b had previously received centralized marketing authorization and is marketed as a monotherapy in cases of intolerance or contraindication to ribavirin for the treatment of adult patients with chronic hepatitis C.

In the malignant melanoma trial and other clinical studies, patients receiving peginterferon alfa-2b experienced mild-to-moderate or severe/life-threatening side effects. The most common side effects of peginterferon alfa-2b are: flu-like symptoms, including headache, fatigue, aches and pains, fevers and chills; depression, nausea, loss of appetite and diarrhea; insomnia; alopecia (hair loss); a reaction at the site of injection; changes in blood liver function tests and in blood c
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Mirus Bio Awarded Grants & Contracts of Over $5 Million
2. FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
3. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
4. NIH grants $750,000 to develop device to determine temperature of neonates brain
5. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
6. Radius Grants Major Pharmaceutical Company Exclusive Option to License BA058 for Osteoporosis
7. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
8. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
9. NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance
10. FDA Grants Resverlogix Approval to Commence a Phase 1 Clinical Trial for RVX-208
11. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... 2014 Each year in the ... medical attention. In the military, burn injury is ... battlefield medical care. More than 800 service members ... wounds heal slowly, remain inflamed and often become ... debilitating and functionally damaging. While developments in supportive ...
(Date:9/29/2014)... start of the military conflicts in Iraq and Afghanistan, ... States with traumatic brain injury caused by exposure to ... explosive devices, or IEDs. Symptoms of traumatic brain injury ... and nausea, to more severe impairments in memory and ... Defense has recognized the critical importance and complexity of ...
(Date:9/29/2014)... Research and Markets  has announced the ... & Services, End-User , Application - Global Forecast to ... The global oligonucleotide synthesis market is expected to reach ... growing at a CAGR of 9.8% from 2014 to ... the basis of products and services, applications, end users, ...
(Date:9/29/2014)... diseases and biodiversity loss requires evolutionary thinking, argues ... Express that was co-authored by Bruce Tabashnik ... and Life Sciences. , For the first time, ... progress in addressing a broad set of challenges ... that consider evolutionary histories and the likelihood of ...
Breaking Biology Technology:Faster Healing with Fewer Scars 2Modeling shockwaves through the brain 2Modeling shockwaves through the brain 3Modeling shockwaves through the brain 4Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 2Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019 3Evolutionary biology: It's not just for textbooks anymore 2Evolutionary biology: It's not just for textbooks anymore 3
... Iceland, Jan. 4 deCODE genetics,(Nasdaq: DCGN ) ... of deCODE,CEO Kari Stefansson,s presentation at the JPMorgan 26th ... 11:30 am PST / 7:30 pm GMT on,Thursday, January ... webcast can be accessed through the Investors page on ...
... to study technology to reduce greenhouse gas emissions, ... Midland,Company (NYSE: ADM ), the Midwest Geological ... (ISGS) announce that they are,working together on a ... and storage of carbon dioxide from ADM,s ethanol ...
... development programs, including review of positive results from the Phase ... ... Jan. 4 QuatRx Pharmaceuticals Company,today announced that the company chief ... 26th Annual JP Morgan Healthcare,Conference on Tuesday, January 8th, 2008, at ...
Cached Biology Technology:ADM, MGSC and ISGS Announce Carbon Sequestration Project 2ADM, MGSC and ISGS Announce Carbon Sequestration Project 3QuatRx Pharmaceuticals to Present at 26th Annual JP Morgan Healthcare Conference 2
(Date:9/29/2014)... Genome Institute (DOE JGI), a DOE Office of ... projects have been selected for the 2015 Community ... Caribbean waters, and from plant root micro-ecosystems, to ... watersheds, the CSP 2015 projects portfolio highlights diverse ... , "These projects catalyze JGI,s strategic shift ...
(Date:9/29/2014)... The BRAF inhibitor dabrafenib has significant anti-tumour activity ... cell lung cancer whose disease has progressed after ... the ESMO 2014 Congress in Madrid, Spain. ... BRAF have generated considerable interest because these mutations ... tyrosine-kinase inhibiting agents," says lead author Dr David ...
(Date:9/29/2014)... Oktoberfest is here, and that means ... for a cold one, taking that first ... chemicals have reacted to form compounds that ... Reactions explains why beers get skunky, and ... brews from going bad. Learn all about ...
Breaking Biology News(10 mins):2015 DOE JGI's science portfolio delves deeper into the Earth's data mine 22015 DOE JGI's science portfolio delves deeper into the Earth's data mine 32015 DOE JGI's science portfolio delves deeper into the Earth's data mine 42015 DOE JGI's science portfolio delves deeper into the Earth's data mine 52015 DOE JGI's science portfolio delves deeper into the Earth's data mine 62015 DOE JGI's science portfolio delves deeper into the Earth's data mine 72015 DOE JGI's science portfolio delves deeper into the Earth's data mine 82015 DOE JGI's science portfolio delves deeper into the Earth's data mine 9Promising results shown with targeted approaches in subsets of non-small cell lung cancer 2Promising results shown with targeted approaches in subsets of non-small cell lung cancer 3
... along the Mississippi River and other areas are altering ... a researcher from Iowa State University. Fred Janzen, ... studied turtle nesting habits and also accumulated research going ... the turtles to find out when they make nests ...
... snakes may slither in saltwater, but they sip the ... zoologist in a paper appearing this month in the ... Physiological and Biochemical Zoology . Harvey Lillywhite ... roughly 60 species of venomous sea snakes worldwide satisfy ...
... incoming administration will confront an array of threats and ... American president, says Steve Fetter, dean of the University ... won, Fetter asked six experts on his faculty with ... recommending steps to address key challenges. Most ...
Cached Biology News:Turtles alter nesting dates due to temperature change says ISU researcher 2Zoologists: Sea snakes seek out freshwater to slake thirst 2Zoologists: Sea snakes seek out freshwater to slake thirst 3Advice to the new administration: UM foreign and domestic policy guide 2Advice to the new administration: UM foreign and domestic policy guide 3Advice to the new administration: UM foreign and domestic policy guide 4Advice to the new administration: UM foreign and domestic policy guide 5Advice to the new administration: UM foreign and domestic policy guide 6Advice to the new administration: UM foreign and domestic policy guide 7
...
Contains L-glutamine....
... Resolution - Efficiently separates ... to 1000 bp. It ... PCR fragments, small DNA ... enzyme digestion, and double-stranded ...
...
Biology Products: